Suppr超能文献

溶酶体膜转运蛋白遗传性疾病。

Inherited disorders of lysosomal membrane transporters.

机构信息

Human Biochemical Genetics Section, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Human Biochemical Genetics Section, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Biochim Biophys Acta Biomembr. 2020 Dec 1;1862(12):183336. doi: 10.1016/j.bbamem.2020.183336. Epub 2020 May 8.

Abstract

Disorders caused by defects in lysosomal membrane transporters form a distinct subgroup of lysosomal storage disorders (LSDs). To date, defects in only 10 lysosomal membrane transporters have been associated with inherited disorders. The clinical presentations of these diseases resemble the phenotypes of other LSDs; they are heterogeneous and often present in children with neurodegenerative manifestations. However, for pathomechanistic and therapeutic studies, lysosomal membrane transport defects should be distinguished from LSDs caused by defective hydrolytic enzymes. The involved proteins differ in function, localization, and lysosomal targeting, and the diseases themselves differ in their stored material and therapeutic approaches. We provide an overview of the small group of disorders of lysosomal membrane transporters, emphasizing discovery, pathomechanism, clinical features, diagnostic methods and therapeutic aspects. We discuss common aspects of lysosomal membrane transporter defects that can provide the basis for preclinical research into these disorders.

摘要

溶酶体膜转运蛋白缺陷引起的疾病构成了溶酶体贮积症(LSDs)的一个独特亚组。迄今为止,只有 10 种溶酶体膜转运蛋白的缺陷与遗传性疾病有关。这些疾病的临床表现与其他 LSD 的表型相似;它们具有异质性,并且常发生在具有神经退行性表现的儿童中。然而,对于发病机制和治疗研究,溶酶体膜转运缺陷应与溶酶体水解酶缺陷引起的 LSD 区分开来。所涉及的蛋白质在功能、定位和溶酶体靶向方面存在差异,并且疾病本身在贮存物质和治疗方法上也存在差异。我们概述了一小群溶酶体膜转运蛋白疾病,重点介绍了这些疾病的发现、发病机制、临床特征、诊断方法和治疗方面。我们还讨论了溶酶体膜转运蛋白缺陷的常见方面,这些方面可以为这些疾病的临床前研究提供基础。

相似文献

1
Inherited disorders of lysosomal membrane transporters.溶酶体膜转运蛋白遗传性疾病。
Biochim Biophys Acta Biomembr. 2020 Dec 1;1862(12):183336. doi: 10.1016/j.bbamem.2020.183336. Epub 2020 May 8.
2
Molecular physiology and pathophysiology of lysosomal membrane transporters.溶酶体膜转运蛋白的分子生理学和病理生理学。
J Inherit Metab Dis. 2008 Apr;31(2):258-66. doi: 10.1007/s10545-008-0879-9. Epub 2008 Apr 15.
3
Sialic acid storage disease and related disorders.唾液酸贮积症及相关疾病。
Genet Test. 2003 Summer;7(2):113-21. doi: 10.1089/109065703322146795.
9
Varied mechanisms underlie the free sialic acid storage disorders.多种机制构成了游离唾液酸贮积症的基础。
J Biol Chem. 2005 Jan 14;280(2):1408-16. doi: 10.1074/jbc.M411295200. Epub 2004 Oct 29.
10
Free sialic acid storage disorder: Progress and promise.游离唾液酸贮积症:进展与前景。
Neurosci Lett. 2021 Jun 11;755:135896. doi: 10.1016/j.neulet.2021.135896. Epub 2021 Apr 20.

引用本文的文献

7
Probing lysosomal activity .探究溶酶体活性
Biophys Rep. 2021 Feb 28;7(1):1-7. doi: 10.52601/bpr.2021.200047.
10
..
Drug Metab Dispos. 2021 Dec 17;50(9):1193-210. doi: 10.1124/dmd.121.000702.

本文引用的文献

3
The CLN3 gene and protein: What we know.CLN3 基因及蛋白:我们已知的知识。
Mol Genet Genomic Med. 2019 Dec;7(12):e859. doi: 10.1002/mgg3.859. Epub 2019 Sep 30.
7
Gene-Based Approaches to Inherited Neurometabolic Diseases.基于基因的遗传性神经代谢疾病治疗方法。
Hum Gene Ther. 2019 Oct;30(10):1222-1235. doi: 10.1089/hum.2019.190. Epub 2019 Sep 10.
8
Gene Therapy Tools for Brain Diseases.用于脑部疾病的基因治疗工具
Front Pharmacol. 2019 Jul 1;10:724. doi: 10.3389/fphar.2019.00724. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验